Alginate-Binding DNA Aptamers for Controlled Hydrogel Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing hydrogel systems, particularly alginate hydrogels, face challenges in controlling the diffusion of biomolecules, leading to rapid release and complicating therapeutic delivery due to the need for specialized fabrication and tight control of morphology and composition.
Innovation Solution
Development of alginate-specific DNA aptamers that bind slowly to alginate hydrogels, acting as anchors for biomolecules, allowing for controlled diffusion and immobilization of human serum albumin (HSA) within the hydrogel environment, enabling testing of drug binding to HSA and subsequent release for analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alginate hydrogels are used to encapsulate biomolecules, then the hydrogels provide biocompatibility and water retention, but the biomolecules diffuse rapidly out of the gel
Solution Approach 1:
The patent introduces DNA aptamers as intermediary molecules that specifically bind to alginate. These aptamers are incorporated into the hydrogel network and create binding sites for biomolecules, effectively mediating between the alginate matrix and the therapeutic agents to reduce their diffusion rate while maintaining gel properties
2Duration of action of moving object
If direct functionalization of hydrogel is performed during crosslinking, then the therapeutic is released slowly, but the fabrication process becomes complicated and tedious
Solution Approach 1:
The patent segments the functionalization process by separating the aptamer incorporation from the therapeutic loading. The aptamers are first incorporated into the alginate hydrogel during crosslinking, creating a pre-functionalized matrix. Subsequently, biomolecules are loaded by simple incubation without requiring complex simultaneous functionalization and gelation procedures
Solution Approach 2:
The aptamers are incorporated into the hydrogel structure during the crosslinking phase as a preliminary action. This pre-functionalization creates binding sites in advance, allowing therapeutic molecules to be loaded in a subsequent simplified step rather than requiring complex integrated fabrication
3Reliability
If nanoparticles are used to control gelation properties, then drug release is improved, but the sample preparation becomes complicated and tedious
Solution Approach 1:
The patent extracts the gelation control function from complex nanoparticle systems and assigns it to simple DNA aptamer-alginate interactions. The aptamers naturally regulate gelation through their specific binding to alginate, eliminating the need for nanoparticle-based gelation control and its associated fabrication complexity
4Duration of action of stationary object
If aptamers are incorporated via hydrogel modification during crosslinking, then gelation and degradation are controlled, but the hydrogel properties must be directly changed
Solution Approach 1:
The patent creates a universal platform where DNA aptamers serve multiple functions: they control gelation through alginate binding, provide structural organization, and create loading sites for diverse biomolecules. This multi-functionality allows the same aptamer-incorporated hydrogel framework to be applied to various therapeutics without requiring specific modifications for each application
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alginate-specific DNA aptamers provide a modular approach to control biomolecule diffusion without altering hydrogel properties, facilitating stable therapeutic delivery and analysis of drug-HSA interactions, enhancing therapeutic efficacy and safety.
Implementation Method 1
DNA aptamers that specifically bind to alginate hydrogels
Implementation Method 2
Alginate forms a hydrogel in the presence of divalent metal ions, such as calcium
Implementation Method 3
relatively rapid diffusion out of the gel
Data Source
AI summary
Disclosed are alginate-specific deoxyribonucleic acid (DNA) aptamers that specifically bind to alginate hydrogels and alginate hydrogels containing alginate-specific DNA aptamers. The alginate-specific DNA aptamers display slower diffusion out of alginate hydrogels and function as anchors for other biomolecules in a wide range of applications.